- This report describes the global market size of Immunology Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.
 
This report covers the following regions:
- North America
 - South America
 - Asia & Pacific
 - Europe
 - MEA
 
For the competitor segment, the report includes global key players as well as some small players.
The information for each competitor includes:
- Company Profile
 - Business Information
 - SWOT Analysis
 - Revenue, Gross Margin and Market Share
 
Applications Segment:
- Hospitals
 - Clinics
 
Types Segment:
- Monoclonal Antibodies
 - Antibody Drug Conjugates
 - Interferon and Cytokine Therapies
 - Immunosuppressive Medication
 
Companies Covered:
- AbbVie
 - Johnson & Johnson
 - Roche
 - Biogen
 - AstraZeneca
 - Novartis
 - Amgen
 - Takeda
 - Pfizer
 - Bristol Myers Squibb
 
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- AbbVie
 - Johnson & Johnson
 - Roche
 - Biogen
 - AstraZeneca
 - Novartis
 - Amgen
 - Takeda
 - Pfizer
 - Bristol Myers Squibb
 - Merck KGaA
 - Sanofi
 - Regeneron Pharmaceuticals
 - GlaxoSmithKline
 - UCB
 - Eli Lilly
 

